[{"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1428-2020", "product_description": "Progesterone 150 mg Troche, 30 troches MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "330 troches", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "02-06-2020:26@15, BUD 8/4/2020  02-07-2020:18@1, BUD 8/5/2020  02-12-2020:43@6, BUD 8/10/2020"}, {"status": "Terminated", "city": "Salem", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83538", "recalling_firm": "Ridge Properties, LLC", "address_1": "4995 Ridge Dr NE", "address_2": "N/A", "postal_code": "97301-7475", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA via internet sales through Amazon.com; ebay.com; Walmart.com; tatbalm.net; Naturallyhl.com", "recall_number": "D-1857-2019", "product_description": "PRE-TAT (lidocaine) 3 in 1 Pre Tattoo Prep With Lidocaine Liquid Gel, 4%, packaged in a) 1 Oz (NDC 69804-019-14), b) 2 Oz (NDC 69804-019-15), and c) 4 Oz (NDC 69804-019-16) bottles, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.", "product_quantity": "109.64 ounces total", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.", "recall_initiation_date": "20190809", "center_classification_date": "20190913", "termination_date": "20230712", "report_date": "20190925", "code_info": "Lot # 1213, Exp 06/05/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-657-2015", "product_description": "Estriol (Ultra-Micronized) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "38769 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Waynesboro", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81811", "recalling_firm": "Duren Health Mart Pharmacy", "address_1": "215 Dexter L Woods Memorial Blvd", "address_2": "N/A", "postal_code": "38485-2416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "TN only", "recall_number": "D-0421-2019", "product_description": "Domperidone 10 mg capsules, 100-count per  prescription, Rx only, Duren's Health Mart Pharmacy  215 Dexter Woods Blvd. Waynesboro, TN 38485,  NDC 00507-2011-00", "product_quantity": "840 capsules", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20181217", "center_classification_date": "20190128", "termination_date": "20220119", "report_date": "20190206", "code_info": "N/A"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81413", "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "address_1": "24416 N 19th Ave", "address_2": "N/A", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide.", "recall_number": "D-0134-2019", "product_description": "Phenylephrine 25 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella of Deer Valley, Inc. #38", "product_quantity": "300 bags", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20181019", "center_classification_date": "20181101", "termination_date": "20210506", "report_date": "20181107", "code_info": "Lot# 138-20182308@88, Exp 11/06/2018"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71553", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1230-2015", "product_description": "Zonisamide capsules, USP 100mg packaged in 10-count blisters (NDC 68084-008-11); 5 blister packs per carton (NDC 68084-008-65); Rx only,  Manufactured by: Wockhardt Limited, Mumbai, India, Distributed by: Wockhardt, USA, LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA for American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217.", "product_quantity": "5,416 cartons", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150601", "center_classification_date": "20150708", "termination_date": "20170222", "report_date": "20150715", "code_info": "Lot#: 132383: Exp Date: 07/31/2015; Lot#: 132989 Exp Date: 10/31/2015; Lot#: 133694 Exp Date: 03/31/2016l Lot#: 134418A Exp Date: 07/31/2016 & Lot#: 134418B Exp Date: 07/31/2016."}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "50", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Lidocaine 2%,  5 mL syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC  45183-0946-70", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1332-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0062-2016", "product_description": "CHORIONIC GONADOTROPIN, Injectable Solution, 1000 UNITS/0.1 mL, 1 mL vial, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "95 vials", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12172014@5, t12162014@23, t09102014@8, t05272015@14, t05222015@20, t03202015@23, t03062015@32, and t02122015@14."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0817-2023", "product_description": "Levocarnitine Oral Solution, USP, 118 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Beverly Hills", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92954", "recalling_firm": "HUMANRACE", "address_1": "9350 Civic Center Dr", "address_2": "", "postal_code": "90210-3629", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Spain, Italy, UK, and France.", "recall_number": "D-1176-2023", "product_description": "Humanrace Suncare, Ozone Body Protection Cream, Broad Spectrum Sunscreen SPF 30, packaged as a 148mL (5 fl oz.) bottle, PA ++++, 100% mineral, Active Ingredient: Zinc oxide 15%, Snow Mushroom, Squalene, Aloe, Dist. By: @Humanrace 2022 Beverly Hills, CA 90210, USA, NDC 82779-002", "product_quantity": "2942 units", "reason_for_recall": "Subpotent Drug: Product does not contain SPF that is declared on the label.", "recall_initiation_date": "20230818", "center_classification_date": "20230921", "report_date": "20230927", "code_info": "Lot #:  1752A, 1752B, 1782E, 1782G, 1782C, 1752C, 1782B; Exp. 06/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0792-2023", "product_description": "Ciclopirox Topical Solution 8% (Nail Lacquer), 6.6 mL bottles, Rx Only, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80964", "recalling_firm": "Takeda Development Center Americas, Inc.", "address_1": "1 Takeda Pkwy", "address_2": "4034BB1", "postal_code": "60015-5713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico", "recall_number": "D-0026-2019", "product_description": "Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals  America, Inc, Deerfield, IL 60015.  NDC: 64764-510-30", "product_quantity": "7,248 bottles", "reason_for_recall": "Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.", "recall_initiation_date": "20180910", "center_classification_date": "20181015", "termination_date": "20200413", "report_date": "20181017", "code_info": "Lot, expiry:  A26004, exp Apr 2020;  A26443 and A26444, exp Sep 2020", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84213", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia", "recall_number": "D-0493-2020", "product_description": "Calcarea Sulphurica  6X Tablets, 300-count bottle, 30g, Manufactured in India exclusively for: Washington Homeopathic Products, Inc., 260 JR Hawvermale Way, Berkeley Springs, WV  25411, barcode 7 40640 64190 3.", "product_quantity": "300 bottles", "reason_for_recall": "CGMP Deviations: products were not manufactured under current good manufacturing practices.", "recall_initiation_date": "20191108", "center_classification_date": "20191118", "termination_date": "20230104", "report_date": "20191127", "code_info": "Lot #: BR18B277"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA065435"], "brand_name": ["PENICILLIN V POTASSIUM"], "generic_name": ["PENICILLIN V POTASSIUM"], "manufacturer_name": ["Rising Health, LLC"], "product_ndc": ["57237-040", "57237-041"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PENICILLIN V POTASSIUM"], "rxcui": ["834061", "834102"], "spl_id": ["2334dad4-7145-499c-959b-bdd69a400ffb"], "spl_set_id": ["54b4d087-cfba-4f6b-918c-eaca0003dbd5"], "package_ndc": ["57237-040-01", "57237-040-99", "57237-041-01", "57237-041-05", "57237-041-99"], "is_original_packager": [true], "upc": ["0357237041017", "0357237040010"], "unii": ["146T0TU1JB"]}, "product_type": "Drugs", "event_id": "76738", "recalling_firm": "Citron Pharma Llc", "address_1": "2 Tower Center Blvd Ste 1101", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0652-2017", "product_description": "Penicillin V Potassium Tablets, USP 500 mg (800,000 units) 1000 count bottles, Rx Only, Distributed by: Citron Pharma LLC, East Brunswick, NJ ---  NDC 57237-041-99", "product_quantity": "420 bottles", "reason_for_recall": "Presence of Foreign Tablet/Capsule; Amoxicillin 500 mg was found in bottles of Penicillin V potassium 500 mg", "recall_initiation_date": "20170224", "center_classification_date": "20170407", "termination_date": "20190909", "report_date": "20170419", "code_info": "Batch Numbers: PE5015069-A, exp 11/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79977", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0823-2018", "product_description": "Loxapine Capsules, USP 50 mg, packaged in 100 Unit Dose capsules, Rx only, Manufactured by Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. NDC 51079-903-20.", "product_quantity": "1,152 blister cards of 100 capsules each", "reason_for_recall": "GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination", "recall_initiation_date": "20180501", "center_classification_date": "20180522", "termination_date": "20210310", "report_date": "20180530", "code_info": "Lot #: 3092310, Exp. 03/2019"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0198-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.25/PGE-1 6 INJ  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06162021:93 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-440-2015", "product_description": "Rose Medical Center (CO) Neonate D5 Bridge, Trophamine 3% Dextrose 5%, Additives: heparin PF 0.5 unit(s)/ml, compound vol: 350 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "2 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74755, Made on 15 DEC 2014, EXP 24 DEC 2014,  CAPS Rx: 37-74755-0-2-R, Disp ID: 37-1124670."}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0358-2017", "product_description": "Glutamine/ORNI/Arginine/LYS/CITRU+LIDO 75 mg/75 mg/150 mg/50 mg/100 mg/10 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "147 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 06232016@14, 07212016@2, 08012016@35, 08192016@11."}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-330-2016", "product_description": "Testosterone CYP/ENAN/PROP Injection, 66.6 mg/66.6. mg/66.6 mg/mL, 5 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "20 vials", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 062915, Exp 09/29/2015; and 071615, Exp 10/16/2015"}, {"status": "Terminated", "city": "Waco", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77143", "recalling_firm": "Allergan Sales, LLC", "address_1": "8301 Mars Dr", "address_2": "N/A", "postal_code": "76712-6578", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0929-2017", "product_description": "Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.", "product_quantity": "648 units", "reason_for_recall": "Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.", "recall_initiation_date": "20170501", "center_classification_date": "20170629", "termination_date": "20190501", "report_date": "20170705", "code_info": "Lot: 93802, EXP NOV 2019"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "96666", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide US.", "recall_number": "D-0396-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-450-17", "product_quantity": "4,885 Bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20250410", "center_classification_date": "20250430", "report_date": "20250507", "code_info": "Lot # D2300044, Exp Date: 12/2025", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; NIACIN TR, Tablet, 250 mg may be potentially mislabeled as    SOLIFENACIN SUCCINATE, Tablet, 5 mg, NDC 51248015001, Pedigree: W003755, EXP: 6/26/2014.", "address_2": "", "product_quantity": "101 Tablets", "code_info": "NIACIN TR, Tablet, 250 mg has the following code    Pedigree: W003756, EXP: 5/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NIACIN TR, Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 10939043533", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-500-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1266-2015", "product_description": "Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 Count Drums, Over the Counter.  Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0374-09.", "product_quantity": "539 Drums", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "Lot #: LN11320, Expiry: 7/31/2015; Lot #: LN11341, Expiry: 8/31/2015."}, {"status": "Terminated", "city": "Noblesville", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72177", "recalling_firm": "Pharmakon Pharmaceuticals", "address_1": "14450 Getz Rd", "address_2": "N/A", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0602-2016", "product_description": "Ketamine 50 mg/mL, injectable packed in syringes, Total dosage 50 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.", "product_quantity": "250", "reason_for_recall": "Stability data does not support expiry.", "recall_initiation_date": "20150819", "center_classification_date": "20160127", "termination_date": "20170509", "report_date": "20160203", "code_info": "All lots with expiration dates up to 11/17/2015"}, {"status": "Terminated", "city": "Murray", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71989", "recalling_firm": "Novacare, LLC", "address_1": "312 W 6100 S", "address_2": "N/A", "postal_code": "84107-6990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0963-2016", "product_description": "Thin and Slim MaxOut Body Max Out FX Fat Burner with Ephedra packaged in containers of 60 capsules.  Distributed by Teamtrade, Inc., Ft. Lauderdale, FL. 1-866-MaxOut www.MaxOutBODY.com.", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.", "recall_initiation_date": "20150824", "center_classification_date": "20160606", "termination_date": "20170830", "report_date": "20160615", "code_info": "unknown"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021545"], "brand_name": ["PATADAY ONCE DAILY RELIEF"], "generic_name": ["OLOPATADINE HYDROCHLORIDE"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-8150"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["OLOPATADINE HYDROCHLORIDE"], "rxcui": ["1111343", "1111345"], "spl_id": ["30e4fc2d-7d06-477a-9160-aa231b83e642"], "spl_set_id": ["1c7d2342-ba1c-4244-9814-d92a05725d4e"], "package_ndc": ["0065-8150-01", "0065-8150-03", "0065-8150-04", "0065-8150-07", "0006581500"], "is_original_packager": [true], "unii": ["2XG66W44KF"]}, "product_type": "Drugs", "event_id": "90553", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1321-2022", "product_description": "Pataday, Once Daily Relief, Olopatadine hydrochloride ophthalmic solution 0.2%, Antihistamine, Eye Allergy Itch Relief, Once Daily, Sterile, 2.5 mL (0.085 FL OZ) bottle per box, Alcon, NDC 0065-8150-01.", "product_quantity": "1 box", "reason_for_recall": "CGMP Deviations: products were stored outside the drug label specifications.", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240213", "report_date": "20220817", "code_info": "Part# 00065815001", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0056-2019", "product_description": "Best Choice, 12 Hour Extra Moisturizing, Nasal Spray (Oxymetazoline Hydrochloride 0.05%), Nasal Decongestant, 1 FL OZ (30 mL) bottle, Proudly Distributed By: Valu Merchandisers, Co., 5000 Kansas Ave., Kansas City, KS 66106, UPC 0 70038 59328 7.", "product_quantity": "2,112 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81344", "recalling_firm": "Bound Tree Medical, LLC", "address_1": "1420 Lakeside Parkway", "address_2": "N/A", "postal_code": "75208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0385-2019", "product_description": "Curaplex Epi Safe Kit, 8600-01102 TRAINING ONLY, Rx Only, Distributed by Sarnova HC, LLC s family of companies: Bound Tree Medical, LLC, Cardio Partners, Inc., Emergency Medical Products, Inc. & Tri-anim Health Services, Inc. 5000 Tuttle Crossing Blvd. Dublin, OH 43016", "product_quantity": "2,654 kits (6 syringes per kit / 1 IFU per kit)", "reason_for_recall": "Labeling Incorrect Instructions:  This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg.", "recall_initiation_date": "20181102", "center_classification_date": "20190118", "termination_date": "20200605", "report_date": "20190130", "code_info": "all lot numbers"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NORTRIPTYLINE HCL, Capsule, 10 mg  may have potentially been mislabeled as the following drug:  VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD70585_1, EXP: 5/29/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "NORTRIPTYLINE HCL, Capsule, 10 mg  has the following codes:  Pedigree: AD70585_4, EXP: 5/29/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NORTRIPTYLINE HCL, Capsule, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093081001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-827-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Charlotte", "address_1": "2815 Coliseum Centre Dr Ste 600", "reason_for_recall": "CGMP Deviations: Product was released to market prior to microbiological testing.", "address_2": "", "product_quantity": "258 cases", "code_info": "Lot 9085", "center_classification_date": "20181106", "distribution_pattern": "NC", "state": "NC", "product_description": "Alcohol Free Foaming Hand Sanitizer (benzalkonium chloride), 0.13%, 1 L (33.8 fl. oz.) cartridge packaged in 8 cartridges per case, Safe-T-Fresh Inc., USA, 2530 Xenium Lane North, Minneapolis, MN 55441.", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "S.C. Johnson Professional", "recall_number": "D-0221-2019", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "81453", "termination_date": "20200908", "more_code_info": "", "recall_initiation_date": "20181026", "postal_code": "28217-0144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90124", "recalling_firm": "Bestco LLC", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "CA, ID, PA, OK", "recall_number": "D-0879-2022", "product_description": "Open Nature Cough Drops Menthol-Cough Suppressant/Oral Anesthetic Peppermint Naturally Flavored, packaged in Bags of 30 lozenges, Distributed By Lucerne Foods, Inc. P.O. Box 99, Pleasanton, CA 96566-0009, UPC 0 79893 41266 5", "product_quantity": "2038 bags", "reason_for_recall": "Subpotent drug: Low OOS for menthol content at the three month room temperature.", "recall_initiation_date": "20220427", "center_classification_date": "20220518", "termination_date": "20240105", "report_date": "20220525", "code_info": "Lot #: 100010885, Exp 11/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M012"], "brand_name": ["GUAIFENESIN AND CODEINE PHOSPHATE"], "generic_name": ["GUAIFENESIN AND CODEINE PHOSPHATE"], "manufacturer_name": ["PAI Holdings, LLC"], "product_ndc": ["0121-0775", "0121-1775", "0121-1550"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CODEINE PHOSPHATE", "GUAIFENESIN"], "rxcui": ["995868"], "spl_id": ["2175415b-f07e-50a6-e063-6394a90acabe"], "spl_set_id": ["88d0994c-4270-4408-8837-bd97510b2118"], "package_ndc": ["0121-0775-04", "0121-0775-08", "0121-0775-16", "0121-1775-05", "0121-1775-00", "0121-1775-10", "0121-1775-40", "0121-1550-10", "0121-1550-00", "0121-1550-40"], "is_original_packager": [true], "nui": ["N0000193956", "N0000008867", "N0000009560"], "pharm_class_epc": ["Expectorant [EPC]"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "unii": ["495W7451VQ", "GSL05Y1MN6"]}, "product_type": "Drugs", "event_id": "96119", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0222-2025", "product_description": "Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16", "product_quantity": "4080 Bottles", "reason_for_recall": "Superpotent; sodium benzoate preservative", "recall_initiation_date": "20250107", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot number 4B07, Exp Date: 2026-OCT-31", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "73718", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1439-2016", "product_description": "Daytrana (methylphenidate transdermal system) Transdermal Patch, 20 mg over 9 hours (2.2 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL  33186; By Noven Pharmaceuticals, Inc., Miami, FL  33186, NDC 68968-5554-3.", "product_quantity": "2088 boxes", "reason_for_recall": "Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.", "recall_initiation_date": "20151221", "center_classification_date": "20160714", "termination_date": "20190319", "report_date": "20160720", "code_info": "Lot # 77140, Exp 05/16", "more_code_info": ""}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1365-2022", "product_description": "BANANA BOAT SPRT CLR SPRY SPF50 6 FL OZ SKU 2007524  SUNTONE SPORT SPRAY SPF 50 5.5 OZ SKU 2096102   HAWAIIAN TROPIC TANNING OIL SPRAY PUMP SPF 25 8 FL OZ SKU 2096111   BANANA BOAT SPORT ULTRAMIST SPRAY SPF 65 6 OZ SKU 2096117   COPPERTONE WATERBABIES LOTION SPF 50 8 FL OZ SKU 2097635   COPPERTONE SPORT SPRAY SPF 50 5.5 OZ SKU 2097636  BANANA BOAT SPRT LTION SPF 50 8 FL OZ SKU 2099592   HAWAIIAN TROPIC SHEER TOUCH LOTION SPF 30 8 FL OZ SKU 2006432   BB KIDS SUN SCREEN MIST SPRAY SPF 100 6 OZ SKU 2007523   SUNTONE KIDS SPRAY SPF 50 6 OZ SKU 2096096  NEUTROGENA BCH DFNSE SPR SPF 70 SKU 2097632   BANANA BOAT KDS SPRT SPRY SPF50 6FL OZ SKU 2097655   BANANA BOAT DRY OIL MST SPRY 15 SPF 6 OZ SKU 2097794   BANANA BOAT TAN DRY OIL MIST 4 SPF 6 OZ SKU 2097144   COPPERTONE GLOW SPRAY SPF 50 5OZ SKU 2096124   COPPERTONE SPORT LOTION SPF 50 8.75 FLOZ SKU 2096130   NEUTROGENA ULTRA SHEER LOTN SPF 55 3 FL OZ SKU 2097637   SUNTONE KIDS LOTION SPF 50 6 FL OZ SKU 2096101   BANANA BOAT SPORT ULTRA MIST 30 SPF 6 OZ SKU 2097141  COPPERTONE SPORT SPRAY SPF30 5.5OZ SKU 2097083   SUNTONE SPORT SPRAY SPF 70 5.5 OZ SKU 2008234   SUNTONE SPORT LOTION SPF 50 6 FL OZ SKU 2096099   COPPERTONE KIDS SPRAY SPF 50 5.5 OZ SKU 2097084   distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKUs: 2007524,  2096102,  2096111,  2096117,  2097635,  2097636,  2099592,  2007523,  2096096,  2097632,  2097655,  2097794,  2097144,  2096124,  2096130,  2097637,  2096101,  2097141,  2097083,  2008234,  2096099,  2097084;  2006432", "more_code_info": ""}, {"country": "United States", "city": "Baltimore", "address_1": "Harborplace Tower", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg", "address_2": "111 S Calvert St Fl 21st", "product_quantity": "11,688 bottles", "code_info": "Lot # Q000232, exp. date 01/2022", "center_classification_date": "20200728", "distribution_pattern": "Product was distributed to OH and may have been further distributed throughout the United States.", "state": "MD", "product_description": "Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08", "report_date": "20200805", "classification": "Class II", "openfda": {"application_number": ["ANDA077321"], "brand_name": ["LISINOPRIL"], "generic_name": ["LISINOPRIL"], "manufacturer_name": ["BluePoint Laboratories"], "product_ndc": ["68001-332", "68001-337", "68001-333", "68001-486", "68001-334", "68001-335", "68001-336"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISINOPRIL"], "rxcui": ["197884", "205326", "311353", "311354", "314076", "314077"], "spl_id": ["c5fac2c4-de1f-49d3-e053-2a95a90a5285"], "spl_set_id": ["34ebeea1-6812-4697-84c4-b2ae4f39e55f"], "package_ndc": ["68001-337-00", "68001-337-08", "68001-332-00", "68001-332-03", "68001-333-00", "68001-333-08", "68001-486-00", "68001-486-08", "68001-334-00", "68001-334-08", "68001-335-00", "68001-335-08", "68001-336-00"], "is_original_packager": [true], "upc": ["0368001334082"], "unii": ["E7199S1YWR"]}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-1413-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "86053", "termination_date": "20210826", "recall_initiation_date": "20200717", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0273-2016", "product_description": "Phenylephrine 1.5%/ Lidocaine 1%, 1 mL Single Use Vial, For Intracameral Injection, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3155-01", "product_quantity": "542 vials", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20151506@31 BUD: 9/13/2015"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0025-2024", "product_description": "fentaNYL, 1,250 mcg/25 mL, (50 mcg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-7", "product_quantity": "1,459 30 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275223, 17-275275, Exp. 10/2/2023; 17-275928, Exp. 10/12/2023; 17-276088, 17-276118, Exp. 10/17/2023."}, {"status": "Terminated", "city": "Fenton", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78678", "recalling_firm": "SSM Health Care St. Louis DBA SSM St. Clare Health Center", "address_1": "1015 Bowles Ave", "address_2": "N/A", "postal_code": "63026-2394", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "SSM Health entities in the state of MO only", "recall_number": "D-0137-2018", "product_description": "Amiodarone 900 mg in dextrose 5% 500 mL, 500 mL bag, Concentration: 1.8 mg/mL, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO.  --- NDC:  88890-0333-01", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product  have been identified as actually containing microorganisms.", "recall_initiation_date": "20170810", "center_classification_date": "20171228", "termination_date": "20180322", "report_date": "20180103", "code_info": "Lot: 170711-005, 10/09/2017"}, {"status": "Terminated", "city": "Long Beach", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73304", "recalling_firm": "Hartley Medical Center Pharmacy, Incorporated", "address_1": "113 W Victoria St", "address_2": "N/A", "postal_code": "90805-2162", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide. No foreign distribution.", "recall_number": "D-0744-2016", "product_description": "Morphine Sulfate 20 mg/ml/Bupivacaine HCL 11.3 mg/ml, vol. 40 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA", "product_quantity": "1 syringe", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160204", "center_classification_date": "20160304", "termination_date": "20160809", "report_date": "20160316", "code_info": "BUD: 5/3/2016"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ACYCLOVIR, Capsule, 200 mg may have potentially been mislabeled as one of the following drugs:   CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD60240_51, EXP: 5/22/2014;  METOPROLOL TARTRATE, Tablet, 25 mg, NDC 57664050652, Pedigree: W002841, EXP: 6/7/2014;  METOPROLOL TARTRATE, Tablet, 50 mg, NDC 00093073301, Pedigree: W003900, EXP: 6/27/2014;  acetaZOLAMIDE", "address_2": "", "product_quantity": "493 Capsules", "code_info": "ACYCLOVIR, Capsule, 200 mg has the following codes:   Pedigree: AD60272_4, EXP: 5/22/2014;  Pedigree: W002899, EXP: 6/10/2014;  Pedigree: W003911, EXP: 6/27/2014;  Pedigree: W003483, EXP: 6/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ACYCLOVIR, Capsule, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093894001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-857-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0291-2023", "product_description": "Ertapenem (Invanz) 1GM  NS 100ML, antibiotic, use with home pump, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "22 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 24-31, 2022"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0876-2019", "product_description": "Dr. King's SafeCare Rx Birth Ease, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955000228, NDC 57955-0002-2", "product_quantity": "44 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 090116E Exp. 09/19"}, {"status": "Terminated", "city": "Lexington", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "68025", "recalling_firm": "Cubist Pharmaceuticals, Inc.", "address_1": "65 Hayden Ave", "address_2": "N/A", "postal_code": "02421-7994", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1382-2014", "product_description": "CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA  02421, NDC 67919-011-01, UPC 3 67919-011-01 6.", "product_quantity": "51,500 vials", "reason_for_recall": "Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.", "recall_initiation_date": "20140417", "center_classification_date": "20140612", "termination_date": "20160722", "report_date": "20140618", "code_info": "Lot #: 280453F, Exp 04/16"}, {"country": "United States", "city": "Las Vegas", "address_1": "5835 S Eastern Ave Ste 101", "reason_for_recall": "Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.", "address_2": "", "product_quantity": "", "code_info": "Lot#: 20180206@3, BUD 03/23/2018; 20180212@15, BUD 03/29/2018, 20180219@16, BUD 04/02/2018.", "center_classification_date": "20180417", "distribution_pattern": "NV only", "state": "NV", "product_description": "TM #3 (ALP10/PAPAV12/PHENT1), 3 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Partell Specialty Pharmacy", "recall_number": "D-0661-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79619", "termination_date": "20190115", "more_code_info": "", "recall_initiation_date": "20180322", "postal_code": "89119-3031", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0488-2018", "product_description": "Estradiol USP (Micronized) (Yam) for prescription compounding, packaged in a) 1g (NDC 58597-8047-1); b) 5g (NDC 58597-8047-3); c) 10g (NDC 58597-8047-4); d) 25g (NDC 58597-8047-5); e) 100 g (NDC 58597-8047-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "2000 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 111516-1, Exp. 09/19/2018; b) 011917A-1, Exp. 09/22/2018;   c) 111516-1, Exp. 09/19/2018; d) 011917A-1, Exp. 09/22/2018; 111516-1, Exp. 09/19/2018; e) 011917A-1, Exp. 09/22/2018; 111516-1, Exp. 09/19/2018"}, {"status": "Terminated", "city": "Tonawanda", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93154", "recalling_firm": "Pine Pharmaceuticals, LLC", "address_1": "355 Riverwalk Pkwy", "address_2": "N/A", "postal_code": "14150-5837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0057-2024", "product_description": "Cefuroxime 4mg /0.4 mL (10 mg/mL), 1mL syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.", "product_quantity": "4972 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231002", "center_classification_date": "20231019", "termination_date": "20240515", "report_date": "20231025", "code_info": "Lot #: 67918, Exp. Date 10/29/2023; 68033, Exp. Date 11/4/2023; 68515, Exp. Date 11/26/2023; 68528, Exp. Date 11/27/2023; 68618, Exp. Date 12/2/2023; 68651, Exp. Date 12/3/2023; 68767, Exp. Date 12/9/2023; 68829, Exp. Date 12/11/2023; 69820, Exp. Date 1/9/2024; 70733, Exp. Date 2/19/2024; 71068, Exp. Date 3/9/2024; 67345, Exp. Date 10/3/2023"}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "95853", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0161-2025", "product_description": "Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.", "product_quantity": "163,883 bottles", "reason_for_recall": "CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.", "recall_initiation_date": "20241206", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot #  222205C, exp. date 11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074649"], "brand_name": ["CARBAMAZEPINE"], "generic_name": ["CARBAMAZEPINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-4005", "51672-4041", "51672-4050", "51672-4123", "51672-4124", "51672-4125", "51672-4047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBAMAZEPINE"], "rxcui": ["197442", "199378", "308973", "308976", "308979", "402505", "402506"], "spl_id": ["3ca9a0ff-e4ac-017c-e063-6394a90a4fc6"], "spl_set_id": ["0526a054-3eda-49b4-b390-7d5d16e30af8"], "package_ndc": ["51672-4041-1", "51672-4041-2", "51672-4041-9", "51672-4041-0", "51672-4050-1", "51672-4005-1", "51672-4005-2", "51672-4005-3", "51672-4123-6", "51672-4123-1", "51672-4123-3", "51672-4124-6", "51672-4124-1", "51672-4124-3", "51672-4125-6", "51672-4125-1", "51672-4125-3", "51672-4047-9", "51672-4047-4"], "is_original_packager": [true], "upc": ["0351672405014", "0351672412418", "0351672404741"], "nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "unii": ["33CM23913M"]}, "product_type": "Drugs", "event_id": "69413", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IL, OH, LA", "recall_number": "D-0049-2015", "product_description": "Carbamazepine Tablets USP, 200 mg, 1000 Tablets per Bottle, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 26110 Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4005-3.", "product_quantity": "1,966 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system.  An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval.", "recall_initiation_date": "20141021", "center_classification_date": "20141027", "termination_date": "20170403", "report_date": "20141105", "code_info": "Lot 137393, exp. 10/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Vasco Da Gama", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090295"], "brand_name": ["METFORMIN HYDROCHLORIDE EXTENDED RELEASE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["TIME CAP LABORATORIES, INC"], "product_ndc": ["49483-623", "49483-624"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["2dc7c971-b13d-eb27-e063-6294a90a5cd1"], "spl_set_id": ["1d8b8970-c2a1-4780-be87-ab8ccfd401fa"], "package_ndc": ["49483-623-09", "49483-623-01", "49483-623-50", "49483-623-10", "49483-624-01", "49483-624-50"], "is_original_packager": [true], "upc": ["0349483624014", "0349483623109", "0349483623017"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85818", "recalling_firm": "Marksans Pharma Limited", "address_1": "& L - 83 Plots L - 82", "address_2": "Verna, Goa", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1356-2020", "product_description": "Time-Cap Labs, Inc. Metformin Hydrochloride Extended-Release Tablets, USP 500 mg Rx Only 100 Tablets bottles, Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA  Manufactured by: Marksans Pharma Ltd. Plot No, L-82, L-83, Verna Intl. Estate, Verna, Goa-403 722, India   NDC 49483-623-01", "product_quantity": "11279 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200605", "center_classification_date": "20200625", "termination_date": "20230907", "report_date": "20200701", "code_info": "XP9004, exp 12/2020"}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91921", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0483-2023", "product_description": "Simvastatin, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0710-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534", "product_quantity": "51 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230313", "center_classification_date": "20230324", "termination_date": "20240617", "report_date": "20230405", "code_info": "Lot, expiry:  03JA2209,  28FE2225, 28AP2211, 07AP2203, exp 6/30/23"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "129 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03222015@23, 5/31/2015; 04072015@68, 7/6/2015; 04142015@76, 7/13/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 50 mg/ml + Clonidine 200 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1610-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0599-2019", "product_description": "Dr. King's Natural Medicine Homeopathic ShinglePlex, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 35795551829, NDC 57955-5518-2", "product_quantity": "1469 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 081815L Exp. 08/18; 010118Q Exp. 01/2020; 050216Z Exp. 05/19; 120616E Exp. 12/19"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022015"], "brand_name": ["MIRALAX"], "generic_name": ["POLYETHYLENE GLYCOL 3350"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["11523-4357", "11523-7268", "11523-7234", "11523-7341"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["POLYETHYLENE GLYCOL 3350"], "rxcui": ["876193", "876195"], "spl_id": ["3ac22f1f-b34c-0c18-e063-6394a90a9742"], "spl_set_id": ["d69ce3d4-7ca4-4fe3-b49e-6655e48d6963"], "package_ndc": ["11523-7268-3", "11523-7268-8", "11523-7268-7", "11523-7268-4", "11523-7268-9", "11523-7268-5", "11523-7234-1", "11523-7234-2", "11523-7234-3", "11523-7234-4", "11523-7234-5", "11523-7234-6", "11523-7234-9", "11523-7341-1", "11523-7341-2", "11523-4357-1", "11523-4357-3", "11523-4357-5", "11523-4357-2", "1152372340"], "is_original_packager": [true], "upc": ["0041100820716", "0041100564542"], "nui": ["N0000010288", "N0000175811", "N0000009871"], "pharm_class_moa": ["Osmotic Activity [MoA]"], "pharm_class_epc": ["Osmotic Laxative [EPC]"], "pharm_class_pe": ["Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "unii": ["G2M7P15E5P"]}, "product_type": "Drugs", "event_id": "90553", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1319-2022", "product_description": "Miralax (Polyethylene Glycol 3350), Powder for Solution, Osmotic Laxative, 30 Once-Daily Doses, Net WT 17.9 OZ (510 g) bottle, Bayer Healthcare Pharmaceuticals, NDC 11523-7234-4.", "product_quantity": "67 bottles", "reason_for_recall": "CGMP Deviations: products were stored outside the drug label specifications.", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240213", "report_date": "20220817", "code_info": "Part# 11523723404", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0940-2020", "product_description": "AscorbiX (Buffered C) Injection, Ascorbix (50ML) 500MG/ML Injectable, For IV, IM, SC Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0226-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 08222019+52828, Exp 2/28/2020; 09092019+52889, Exp 3/17/2020; 09182019+52924, Exp 3/26/2020; 09262019+52971, Exp 4/3/2020; 10142019+53108, Exp 4/21/2020; 10212019+53136, Exp 4/28/2020; 10302019+53164, Exp 5/7/2020; 11252019+53278, Exp 6/2/2020; 11262019+53284, Exp 6/3/2020"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0017-2024", "product_description": "fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2", "product_quantity": "190 250 mL bags", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot: 17-275974, 17-275979, Exp. 10/15/2023; 17-276110, Exp. 10/17/2023; 17-276234, Exp. 10/19/2023."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70303", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0969-2015", "product_description": "0.9% Sodium Chloride Injection, USP, 250 mL, Rx Only, Hospira Inc., Lake Forest, IL, 60045, USA, NDC 0409-7983-02", "product_quantity": "661,128 containers", "reason_for_recall": "Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.", "recall_initiation_date": "20150120", "center_classification_date": "20150423", "termination_date": "20170117", "report_date": "20150429", "code_info": "Lot #: 44-002-JT (the lot number may be followed by 01 to 99), Exp 08/01/2016", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87452", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0309-2021", "product_description": "Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Pharmaceuticals USA, Inc. NDC 0703-4004-01", "product_quantity": "1,416 vials", "reason_for_recall": "Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.", "recall_initiation_date": "20210304", "center_classification_date": "20210319", "termination_date": "20220519", "report_date": "20210324", "code_info": "Lot # 31328184C, exp. date 11/2021  Lot # 31327686C, exp. date 08/2021  Lot # 31327685C, exp. date 08/2021"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0140-2023", "product_description": "GONAK Hypromellose Ophthalmic Demulcent Solution, (25 mg) 2.5%, 15 mL per dropper bottle, For Professional Use in Goinoscopic Examinations, Mfd. by: Akorn, INc., Lake Forest, IL 60045.  NDC: 17478-064-12", "product_quantity": "196,254 bottles", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: 0C80A, EXP 2/28/2023; 0B71A, 1B32A, EXP 1/31/2023; 0C80B, EXP 2/28/2023; 0F68A, EXP 5/31/2023;  0G85A, 0G01A, 1G54A, 1G71A, EXP 6/30/2023; 0H32A, 0H47A, 1H75A, EXP 7/31/2023; 0K22A, EXP 9/30/2023; 0M90A, EXP 11/30/2023;"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "77393", "recalling_firm": "Teva Pharmaceuticals", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0960-2017", "product_description": "Paliperidone Extended-Release Tablets, 3 mg, 90 count bottles, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA  Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, NDC: 0591-3693-19", "product_quantity": "360 bottles", "reason_for_recall": "Failed Dissolution Specifications: Drug release test result, obtained during routine 9-month stability testing, which was below specification for one tablet. Teva cannot at this time exclude the potential for additional tablets to be below specification.", "recall_initiation_date": "20170531", "center_classification_date": "20170711", "termination_date": "20180329", "report_date": "20170719", "code_info": "Lot: 1160682A, EXP. 06/18", "more_code_info": ""}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Progesterone Cyp Inj, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0445-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81004", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-0084-2019", "product_description": "Cortaid Intensive Therapy Cooling Spray (1% hydrocortisone), 2 FL OZ (59 mL) spray bottle, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875518028", "product_quantity": "18,408 bottles", "reason_for_recall": "CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.", "recall_initiation_date": "20180824", "center_classification_date": "20181022", "termination_date": "20200306", "report_date": "20181031", "code_info": "Lot #: 171205E, 171951E, Exp 5/19; 173365K, Exp 10/19"}, {"status": "Terminated", "city": "Billerica", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018124"], "brand_name": ["KIT FOR THE PREPARATION OF TECHNETIUM TC 99M MEDRONATE"], "generic_name": ["TC 99M MEDRONATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["45567-0040"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TECHNETIUM TC-99M MEDRONATE"], "spl_id": ["3010d5a9-2402-c30a-e063-6394a90a73ab"], "spl_set_id": ["703d347c-e240-408a-b69d-9713e958a201"], "package_ndc": ["45567-0040-1", "45567-0040-2"], "is_original_packager": [true], "nui": ["N0000177914", "N0000000205"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "unii": ["X89XV46R07"]}, "product_type": "Drugs", "event_id": "80428", "recalling_firm": "Pharmalucence, Inc.", "address_1": "29 Dunham Rd", "address_2": "N/A", "postal_code": "01821-5729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-1040-2018", "product_description": "Kit for the Preparation of Technetium Tc99m Medronate, 20mg in 10 mL vial, packaged in a) 5-count box (NDC 45567-0040-1), b) 30-count box, NDC 45567-0040-2 , Rx only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821.", "product_quantity": "95 kits", "reason_for_recall": "Lack of assurance of sterility: Technetium TC-99M Medronate Kit has a reported breach of sterility.", "recall_initiation_date": "20180606", "center_classification_date": "20180803", "termination_date": "20190311", "report_date": "20180815", "code_info": "Lot 4223"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0169-2018", "product_description": "Chloramphenicol 50 mg/ Sulfamethoxazole 50 mg/ Amphotericin-B 5 mg capsules, For OTIC Use Only, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "90 capsules", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 08212017@24 BUD: 2/17/2018", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "315 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03102015@55, 3/9/2016; 03172015@62, 3/16/2016; 04102015@7, 4/9/2016", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Mitomycin 40 mg/50 ml Sodium Chloride 0.9% Injection, Single Dose Syringe, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1584-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0341-2016", "product_description": "Acetyl-L-Carnitine Injectable, 100mg/mL, 30mL vial, L-Carnitine Injection 500mg/mL, 30mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "108 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90003", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Alabama", "recall_number": "D-0790-2022", "product_description": "Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59", "product_quantity": "97,975 vials", "reason_for_recall": "Subpotent Drug: Out of specification for assay.", "recall_initiation_date": "20220412", "center_classification_date": "20220426", "termination_date": "20221228", "report_date": "20220504", "code_info": "Lots: CCC210008, CCC210009, Exp. 01/23", "more_code_info": ""}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA078020"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6321", "0378-6322", "0378-6323", "0378-6324", "0378-6325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["16044239-373d-4b04-9a4d-fd4232a93b6c"], "spl_set_id": ["3ba1f9f9-0037-4522-8605-e27dc8552b5b"], "package_ndc": ["0378-6321-77", "0378-6321-05", "0378-6322-77", "0378-6322-05", "0378-6323-77", "0378-6323-05", "0378-6324-77", "0378-6324-05", "0378-6325-77", "0378-6325-05"], "is_original_packager": [true], "upc": ["0303786323777"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0329-2019", "product_description": "Valsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b) 500-count bottles (NDC 0378-6322-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "50,595 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers:  2008880    3084358    3084359    3093801    3084359    3084361    3093801"}, {"status": "Terminated", "city": "Salem", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78462", "recalling_firm": "Ridge Properties, LLC", "address_1": "4995 Ridge Dr NE", "address_2": "N/A", "postal_code": "97301-7475", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product distributed throughout United States.", "recall_number": "D-0089-2018", "product_description": "Extra Strength Naturally HL  Liquid Hemorrhoid Relief Gel, (lidocaine HCL 4%), 1/2 oz Liquid Gel (NDC 69804-024-13), 1 oz Liquid Gel (NDC 69804-024-14), 2 oz Liquid Gel (NDC 69804-024-15), 4 oz Liquid Gel (NDC 69804-024-16) bottles, Manufactured by Pain Relief Naturally, www.Naturally HL.com", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations: inadequate manufacturing control processes", "recall_initiation_date": "20171103", "center_classification_date": "20171121", "termination_date": "20190114", "report_date": "20171129", "code_info": "All batches and lots, exp 10/17/2018. Not all batches were assigned lot numbers"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-883-2015", "product_description": "Rocuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1550 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Texarkana", "address_1": "7400 Alumax Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Product(s): The product was found to be contaminated with Bulkholderia sp.", "address_2": "", "product_quantity": "", "code_info": "a) Good Neighbor Pharmacy Mercuroclear  2 fl. oz, Lots: ALL LOTS    b) Quality Choice Mercuroclear  2 fl. oz, Lots: ALL LOTS    c) Select Brand Mercuroclear  2 fl. oz, Lots: ALL LOTS    d) Premier Value Mercuroclear  2 fl. oz, Lot: ALL LOTS    e) Rite Aid Mercuroclear  2 fl. oz, Lots: ALL LOTS    f) Top Care Mercuroclear  2 fl. oz , Lots: ALL LOTS    g) Vida Mia Mercuroclear, 2 fl. oz. Lots: ALL LOTS    h) HUMCO Mercuroclear 2 fl oz. sold to WalMart Lots: ALL LOTS     i) HUMCO Mercuroclear 3 fl. oz. Lots: ALL LOTS", "center_classification_date": "20140130", "distribution_pattern": "Nationwide", "state": "TX", "product_description": "Mercuroclear Antiseptic Anesthetic First Aid Helps prevent infection and relieves pain and itching of minor cuts, scrapes, burns and insect bites.  Aqueous solution. Active Ingredients Benzalkonium chloride 0.13% - First Aid antiseptic, Lidocaine hydrochloride 2.5% - External analgesic. Sold under the following brands: a) Good Neighbor Pharmacy NDC 24385-593-46 , b) Quality Choice, NDC 63868-0488-02; c) Select Brand NDC 15127-885-59; d) Premier Value UPC 4098602556; e) Rite Aid Pharmacy UPC 011822576871; f) TopCare UPC 3680033436; g) Vida Mia UPC 847717060718; h) Humco 2 fl. oz NDC 0395-1637-92 i) Humco 3 fl. oz. NCD 0395-1637-93 ; 2 fl OZ (59 mL) and 3 FL OZ (90 mL) bottles, HUMCO, Texarkana, TX 75501.", "report_date": "20140205", "classification": "Class II", "openfda": {}, "recalling_firm": "Humco Holding Group, Inc", "recall_number": "D-1048-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "66927", "termination_date": "20170126", "more_code_info": "", "recall_initiation_date": "20131126", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0447-2019", "product_description": "Thymosin Beta-4, 15 mg Injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "94 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 08302018@8 BUD: 2/26/2019; 10012018@2 BUD: 3/30/2019; 07052018@2 BUD: 01/01/2019"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0191-2022", "product_description": "TRI-MIX PAPAVERINE 18/PHENTOL 0.6/PGE-1 5.88/ML INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08062021:45 BUD: 11/30/2021; 07132021:75 BUD: 10/23/2021", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "162 syringe", "code_info": "Lot: 165538", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Lidocaine HCl 1%, 10 mL Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0197-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "99 mL total", "code_info": "All lots distributed between November 2014 and May 2015;    05042015@39, 6/8/2015; 04212015@3, 5/26/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Acetylcysteine 100 mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1435-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "2681 bags", "code_info": "Lot: 9210", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Oxytocin 30 USP Units Added to 0.9% Sodium Chloride, 500 mL Bag, Single-Dose Bag,  Injection Solution for IV Use Only, Rx Only, Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-056-30", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0201-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0414-2021", "product_description": "Vaniqa (eflornithine hydrochloride) Cream, 13.9% For Topical Use Only Net wt. 1.59 oz (45 g) Rx only NDC 0023-4857-45 Manufactured for Allegan, Inc. Irvine, CA 92612", "product_quantity": "72 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "113780"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020064"], "brand_name": ["MACROBID"], "generic_name": ["NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE"], "manufacturer_name": ["Almatica Pharma LLC"], "product_ndc": ["52427-285"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NITROFURANTOIN", "NITROFURANTOIN MONOHYDRATE"], "rxcui": ["539712", "1648755"], "spl_id": ["83236f78-20ec-6005-4b09-cc2470a1b36a"], "spl_set_id": ["8f270a9f-12a1-44d4-bc7e-873613555801"], "package_ndc": ["52427-285-01"], "is_original_packager": [true], "upc": ["0352427285011"], "nui": ["N0000175494", "M0014892"], "pharm_class_epc": ["Nitrofuran Antibacterial [EPC]"], "pharm_class_cs": ["Nitrofurans [CS]"], "unii": ["927AH8112L", "E1QI2CQQ1I"]}, "product_type": "Drugs", "event_id": "83434", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Natonwide, PR", "recall_number": "D-1723-2019", "product_description": "Macrobid Urinary Tract Anitbacterial, 100 mg,  100-count bottle, Rx Only, Mfg. by: Norwich Pharmaceuticals, Inc. Norwich, NY 13815 USA Dist. by: Almatica Pharma, Inc. Pine Brook, NJ 07058 USA, NDC 52427-285-01", "product_quantity": "4272 bottles", "reason_for_recall": "Failed dissolution specifications", "recall_initiation_date": "20190724", "center_classification_date": "20190812", "termination_date": "20210804", "report_date": "20190821", "code_info": "Lot # 472990, Exp 03/2020"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0144-2022", "product_description": "SERMORELIN ACETATE 6MG/IPAMORELIN 6MG - LYOPHILIZED   6MG/6MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "11 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06022021:03 BUD: 11/29/2021; 08102021:27 BUD: 11/30/2021; 05212021:84 BUD: 11/17/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206028"], "brand_name": ["MEMANTINE HYDROCHLORIDE"], "generic_name": ["MEMANTINE HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-246", "68180-249", "68180-247", "68180-248"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MEMANTINE HYDROCHLORIDE"], "rxcui": ["996594", "996603", "996609", "996615"], "spl_id": ["e7dc37e2-b1d1-4abf-89a4-6cffd5392597"], "spl_set_id": ["24290655-47f3-4042-a977-a832c5161d2c"], "package_ndc": ["68180-246-06", "68180-249-06", "68180-249-09", "68180-249-02", "68180-247-06", "68180-247-09", "68180-248-06"], "is_original_packager": [true], "unii": ["JY0WD0UA60"]}, "product_type": "Drugs", "event_id": "84948", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States.", "recall_number": "D-0855-2020", "product_description": "Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States. Manufactured by: Lupin Limited Pithampur (M.P.)-454 775, INDIA, NDC 68180-248-06", "product_quantity": "6,294 bottles", "reason_for_recall": "Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.", "recall_initiation_date": "20200212", "center_classification_date": "20200224", "termination_date": "20210603", "report_date": "20200219", "code_info": "Lot #: H900330, exp. date 11/2020.", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0302-2024", "product_description": "Velocity Pharma brand Lubricating Eye Drop (Propylene glycol Eye Drops 0.6%), packaged in 3 bottles of 0.33 FL OZ (10 mL) each, Velocity Pharma, NDC 76168-502-30", "product_quantity": "2,820 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0563-2025", "product_description": "Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "190 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-329-2016", "product_description": "Testosterone Cypionate 200 mcg/mL in Corn Oil Injection, 5 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 070115, Exp 10/01/2015; and 071015, Exp 10/10/2015"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-948-2015", "product_description": "Valacyclovir HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "3050 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0089-2017", "product_description": "rocuronium Bromide, 10 mg per mL, 50 mg per 5 mL, Preservative Free, 5 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3321.", "product_quantity": "6970 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 151120168M, 151120169M, 15112027M, 15112096M, 15113021M, 15113080M, 15113081M, 15113082M, 15113083M, 15113084M, 15113085M, 15113086M, 15113087M, 15113088M, Exp between 07/15/15-10/12/15"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Glutathione 300 mg/1.5 mL Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0408-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85842", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1372-2020", "product_description": "Nabumetone Tablets, USP, 500 mg, 100 Tablets per carton (10 tablets x 10 blister cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC carton: 60687-374-01, NDC unit dose: 60687-374-11", "product_quantity": "265 cartons", "reason_for_recall": "Labeling Not Elsewhere Classified: The statement  Pharmacist: Dispense with the accompanying Medication Guide  was not included on the carton label.", "recall_initiation_date": "20200610", "center_classification_date": "20200701", "termination_date": "20220803", "report_date": "20200701", "code_info": "Lot #: 189551, Exp 04/30/2021"}, {"status": "Ongoing", "city": "Tesuque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92952", "recalling_firm": "Dr. Berne's Whole Health Products", "address_1": "174 Tesuque Village Rd Unit 458", "address_2": "N/A", "postal_code": "87574-2030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and UK, Canada, Italy, India, Australia, Germany, Switzerland, Singapore, Netherlands, Ireland, South Korea, Belgium, Norway, Saudi- Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, Barbados.", "recall_number": "D-0035-2024", "product_description": "Dr. Berne's Organic Castor Oil Eye Drops, Net WT 30 mL/1 fl oz bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM, 87574, hello@drsamberne.com, Certified Organic by Organic Certifiers.", "product_quantity": "1744 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230826", "center_classification_date": "20231004", "report_date": "20231011", "code_info": "Lot: 6666, Exp. 11/30/25"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202717"], "brand_name": ["MONTELUKAST SODIUM"], "generic_name": ["MONTELUKAST SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-119"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MONTELUKAST SODIUM"], "rxcui": ["200224"], "spl_id": ["d481e75b-ffed-a218-e053-2995a90a19c5"], "spl_set_id": ["6eea668f-a2fa-447f-b2d5-4c754d13d9fa"], "package_ndc": ["16729-119-10", "16729-119-15", "16729-119-17"], "is_original_packager": [true], "upc": ["0316729119108", "316729119108", "316729119153", "316729119177"], "unii": ["U1O3J18SFL"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0400-2023", "product_description": "Montelukast Sodium Tablets, USP, 10 mg* Rx Only, Packaged as: a) 30-count bottle NDC 16729-119-10 UPC 3 16729 11910 8; b) 90-count bottle NDC 16729-119-15 UPC 3 16729 11915 3; c) 1,000-count bottle NDC 16729-119-17 UPC 3 16729 11917 7; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "665,469 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a) R2000831, Exp. Date 11/30/2023; R2000832, Exp. Date 11/30/2023; R2200661, Exp. Date 5/31/2025;  b)R2000836, R2000837, R2000838, R2000840, R2000842, R2000835, R2000841, R2000833, Exp. Date 11/30/2023; R2100310, R2100311, R2100314, R2100312, R2100313, R2100315, R2100316, R2100317, R2100318, Exp. Date 2/29/2024; R2100859, Exp. Date 5/31/2024; R2100940, R2100993, Exp. Date 7/31/2024;  c) R2000473, Exp. Date 8/31/2023; R2000517, Exp. Date 9/30/2023; R2100036, R2100005, R2100037, R2100002, R2100040, R2100044, R2100045, R2100039, R2100038, R2100104, R2100047, R2100048, R2100046, R2100049, R2100056, R2100057, R2100101, R2100058, R2100050, R2100103, R2100102, R2100116, R2100108, R2100105, R2100123, R2100117, R2100118, R2100121, R2100122, R2100128, R2100119, R2100124, Exp. Date 12/31/2023; R2100124, R2100182, R2100184, R2100183, R2100188, R2100189, R2100186, R2100222, R2100197, R2100198, R2100203, R2100192, R2100196, R2100202, R2100199, R2100200, R2100223, R2100224, R2100225, R2100226, R2100228, R2100245, R2100227, R2100230, R2100229, Exp. Date 1/31/2024; R2100246, R2100253, R2100249, R2100251, R2100248, R2100263, R2100254, R2100264, R2100265, R2100266, R2100255, R2100256, R2100257,Exp. Date 2/29/2024; R2100445, R2100446, R2100449, R2100450, R2100451, Exp. Date 3/31/2024; R2100544, R2100545, R2100549, R2100550, R2100567, R2100568, R2100574, R2100576, R2100577, Exp. Date 4/30/2024; R2100594, R2100610, R2100600, R2100624, R2100626, R2100662, R2100661, R2100629, R2100776, R2100693, R2100681, R2100684, Exp. Date 5/31/2024; R2100725, R2100724, R2100726, R2100816, R2100804, R2100815, R2100834, R2100841, Exp. Date 6/30/2024; R2200188, R2200196, R2200195, Exp. Date 1/31/2025; R2200368, R2200366, R2200503, Exp. Date 3/31/2025; R2200659, R2200660, R2200751, R2200759, R2200761, R2200763, Exp. Date 5/31/2025; R2201016, R2201014, Exp. Date 7/31/2025;", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0109-2022", "product_description": "CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "15 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 05242021:73 BUD: 08/22/2021; 08032021:26 BUD: 11/01/2021; 06022021:49 BUD: 08/31/2021; 08122021:97 BUD: 11/10/2021;", "more_code_info": ""}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1221-2022", "product_description": "Pentosan Polysulfate Sodium 250mg/mL, 5mL-vial,  Room Temperature, Tailor Made Compounding", "product_quantity": "220 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 11292109A2, Exp 5/28/2022, 01242202A1, Exp 6/18/2022; 03022214A1, Exp 8/29/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206321"], "brand_name": ["SAXENDA"], "generic_name": ["LIRAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2800"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["LIRAGLUTIDE"], "rxcui": ["897122", "1598268"], "spl_id": ["49c3d82d-a708-46b2-a273-6ea032afa5c3"], "spl_set_id": ["3946d389-0926-4f77-a708-0acb8153b143"], "package_ndc": ["0169-2800-15", "0169-2800-90", "0169-2800-97"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["839I73S42A"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0618-2021", "product_description": "Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample. Not for Resale., Rx only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark,  NDC 0169-2800-90 (Pen), NDC 0169-2800-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "K1620A1 (Kit); KZFH714 (Pen) exp 05/31/2022;   B2020A (Kit); JZFF482 (Pen) exp 11/30/2021;   I2320A (Kit); KZFH714 (Pen) exp 05/31/2022;   H1020A (Kit); KZFH714 (Pen) exp 05/31/2022;  J0520A(Kit); KZFH714 (Pen) exp 05/31/2022"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72214", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0163-2016", "product_description": "Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130.  NDC: 68012-495-90.", "product_quantity": "3341 Bottles", "reason_for_recall": "Failed Dissolution Specifications: Failed 24 month dissolution testing.", "recall_initiation_date": "20150904", "center_classification_date": "20151103", "termination_date": "20170314", "report_date": "20151111", "code_info": "Lot # 1300939, Expiry: March 2016."}, {"country": "United States", "city": "Lake Forest", "address_1": "275 N Field Dr", "reason_for_recall": "Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.", "address_2": "", "product_quantity": "98,084 units", "code_info": "Lots #: 04-151-JT, 06-040-JT, Exp 4/13", "center_classification_date": "20130621", "distribution_pattern": "Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia", "state": "IL", "product_description": "0.9% Sodium Chloride Irrigation, USP, 3000 mL, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7972-08", "report_date": "20130703", "classification": "Class II", "openfda": {}, "recalling_firm": "Hospira Inc.", "recall_number": "D-617-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61918", "termination_date": "20150717", "more_code_info": "", "recall_initiation_date": "20120504", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Rahway", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206829"], "brand_name": ["ZERBAXA"], "generic_name": ["CEFTOLOZANE AND TAZOBACTAM"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "product_ndc": ["67919-030"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CEFTOLOZANE SULFATE", "TAZOBACTAM SODIUM"], "rxcui": ["1597615", "1597620"], "spl_id": ["22bf0411-3002-43cd-a13f-1a18b519e0ae"], "spl_set_id": ["70ac1d90-eff3-4f0b-9f46-5846c571b32f"], "package_ndc": ["67919-030-01"], "is_original_packager": [true], "unii": ["7R247U84HY", "UXA545ABTT"]}, "product_type": "Drugs", "event_id": "87018", "recalling_firm": "Merck Sharp & Dohme", "address_1": "126 E Lincoln Ave", "address_2": "", "postal_code": "07065-4607", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0176-2021", "product_description": "Zerbaxa (ceftolozane and tazobactam) 1.5g per vial for injection, Single-Dose vial, Rx only, Manuf. for: Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc., NDC 67919-030-01", "product_quantity": "106,503 vials", "reason_for_recall": "Lack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches produced turbid results that could not be further identified. While all product distributed to the market has met the registered specifications for release, including for sterility, it was manufactured on the same equipment as the affected batches.", "recall_initiation_date": "20201221", "center_classification_date": "20210107", "termination_date": "20231204", "report_date": "20210113", "code_info": "All lots within expiry:  SP1488 08-Jun-21; SP1490 11-Jun-21; SP1492 13-Jun-21; SP1493 15-Jun-21; SP1494 21-Jun-21; SP1495 23-Jun-21; SP1496 25-Jun-21; SP1497 27-Jun-21; SP1498 29-Jun-21; SP1509 20-Sep-21; SP1510 26-Sep-21; SP1515 16-Oct-21; SP1517 23-Oct-21; SP1518 25-Oct-21; SP1519 30-Oct-21; SP1520 01-Nov-21; SP1521 06-Nov-21; SP1522 08-Nov-21; SP1523;13-Nov-21; SP1524; 15-Nov-21; SP1525 20-Nov-21; SP1526 27-Nov-21; SP1537 11-Jan-22; SP1564 17-Oct-22; SP1567 16-Oct-22; SP1572 24-Oct-22; SP1573; 28-Oct-22; SP1574  29-Oct-22; SP1584; 14-Nov-22; SP1586; 15-Nov-22; SP1588; 19-Nov-22; SP1593 03-Dec-22; SP1602 18-Dec-22; SP1603; 19-Dec-22; SP1606 08-Jan-23; SP1609 15-Jan-23; SP1610 20-Jan-23; SP1611 22-Jan-23; SP1626 13-Apr-23; SP1629  17-Apr-23; SP1633 21-Apr-23", "more_code_info": ""}, {"status": "Terminated", "city": "Lewisburg", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89705", "recalling_firm": "Tennessee Technical Coatings, Corp.", "address_1": "1421 Higgs Rd", "address_2": "N/A", "postal_code": "37091-4401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed in AL, TN", "recall_number": "D-0739-2022", "product_description": "HAND SANITIZER Isopropyl Alcohol Antiseptic 75%, Net contents: 1 U.S. Gallon/3.785 Liters  Tennessee Technical Coatings Corporation, 1421 Higgs Road (P.O. Box 1698) Lewisburg, TX 37091, NDC 76921-000-01", "product_quantity": "169.2 gallons", "reason_for_recall": "Chemical Contamination: FDA analysis found 1 lot of   HAND SANITIZER Isopropyl Alcohol Antiseptic 75%, to contain methanol.", "recall_initiation_date": "20220303", "center_classification_date": "20220404", "termination_date": "20221202", "report_date": "20220330", "code_info": "Batch #:00806001, No EXP date on label."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-200-2014", "product_description": "Medroxyprogesterone 150mg 10ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "5 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Wayne", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62651", "recalling_firm": "Bayer HealthCare Pharmaceuticals Inc.", "address_1": "6 W Belt Plz", "address_2": "N/A", "postal_code": "07470", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and California.", "recall_number": "D-1433-2012", "product_description": "Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.", "product_quantity": "112.295 kg", "reason_for_recall": "Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.", "recall_initiation_date": "20120508", "center_classification_date": "20120731", "termination_date": "20121218", "report_date": "20120808", "code_info": "Lot Number: 81202450, Exp 06/15/16"}, {"country": "United States", "city": "Raleigh", "address_1": "2601 Blue Ridge Rd", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "3 Vials", "code_info": "All Lots", "center_classification_date": "20140109", "distribution_pattern": "NC", "state": "NC", "product_description": "Super Triple Mix Injectable, (aka Dr Lentz Triple Rx Injectable; Dr Kane's Super Triple Rx Injectable; Dr Tortora's Super Triple Rx Injectable), 5 mL vial, Rx Only, The Compounding Center at Blue Ridge, 2601 Blue Ridge Rd, Raleigh, NC 27607.", "report_date": "20140115", "classification": "Class II", "openfda": {}, "recalling_firm": "Compounding Centre At Blue Ridge", "recall_number": "D-403-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66568", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20131018", "postal_code": "27607-6481", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0523-2023", "product_description": "Simvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9", "product_quantity": "57 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "Lot: B0222S, Exp 2/29/2024; Lot: F1121B, G2721L, Exp 11/30/2023.", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "4 ml", "code_info": "All lots distributed between November 2014 and May 2015;  04232015@36, 6/22/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "HCG 1,000 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, 23 DAY KIT, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1512-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]